Just in time for the lead-up to the annual JP Morgan Healthcare Conference (follow at #JPM16), the Biotech Tweets of the Week returns to recap the the highlights of the first big news week of 2016. As always, the collection is curated by @23aloha and @BioDueDiligence.
Biotech Tweets of the Week (January 4-, 2016), featuring:
Biotech Tweets of the Week (January 4-, 2016), featuring:
- CRISPR player Editas headlines IPO boomlet $EDIT
- Mannkind faces the end of the road for Afrezza $MNKD $SNY
- Biotechs raise money $EPZM and many more
- Dynavax and uniQure pick a bad day for good news $DVAX $QURE
- As seen on the stream (the best of everything else new and noteworthy...)
RSS Feed
